ScoreWhy is Venmax Drugs & Pharmaceuticals Ltd ?
1
Flat results in Dec 25
2
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -1.60%, its profits have fallen by -7%
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -1.60% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Venmax Drugs for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Venmax Drugs
-1.6%
-0.03
52.13%
Sensex
-3.52%
-0.27
12.93%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
81.00%
EBIT Growth (5y)
-95.00%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.56
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.73%
ROE (avg)
0.09%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
27
Industry P/E
32
Price to Book Value
5.30
EV to EBIT
-20.78
EV to EBITDA
-20.78
EV to Capital Employed
10.82
EV to Sales
4.71
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-52.08%
ROE (Latest)
19.82%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
PAT(Latest six months)
Higher at Rs 0.05 cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Venmax Drugs
Profit After Tax (PAT) - Latest six months
Higher at Rs 0.05 cr
than preceding 12 month period ended Dec 2025 of Rs 0.02 crMOJO Watch
In the half year the company has already crossed PAT of the previous twelve months
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
